Home
Sponsors
Program
Sessions
Open menu
Session 1
Session 2
Session 3
Session 4
Session 6
Session 7
Session 9
Session 10
Session 12
Session 13
Conferences
Open menu
Welcome
Closing Conference
Posters
Open menu
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Round Tables
Open menu
Round Table 1
Round Table 2
Round Table 3
Meeting Policies
Menu
Home
Sponsors
Program
Sessions
Open menu
Session 1
Session 2
Session 3
Session 4
Session 6
Session 7
Session 9
Session 10
Session 12
Session 13
Conferences
Open menu
Welcome
Closing Conference
Posters
Open menu
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Round Tables
Open menu
Round Table 1
Round Table 2
Round Table 3
Meeting Policies
Poster Session 3
May 20 · 10:30 - 12:30
CHAIRS
Matías Blaustein
iB3-DFBMC-FCEyN-UBA and CONICET, Buenos Aires, Argentina
Germán Gil
CIQUIBIC CONICET, Universidad Nacional de Córdoba, Córdoba, Argentina.
Natalia Rubinstein
iB3-DFBMC-FCEyN-UBA and CONICET, Buenos Aires, Argentina
PS3-36.
Role of Thyroid Hormones in breast cancer resistance to chemotherapy
PS3-37.
ACE2 downregulation as a resistance mechanism to VEGFR-tyrosine kinase inhibitor (VEGFR-TKI) treatment in breast cancer therapy
PS3-38.
Cytokinesis inhibition induces synthetic lethality and mitotic abnormalities in BRCA2-deficient cell lines
PS3-39.
Emerging role of AhR / c-Src signaling in breast cancer cell migration induced by tumor acidosis
PS3-40.
Soluble tumor necrosis factor alpha fosters tumor growth, innate immune evasion and resistance to lapatinib in HER2-positive breast cancer
PS3-41.
Effect of Lapatinib and All-Trans Retinoic Acid (ATRA) combined treatment on mammary cancer stem cells derived from HER2 negative cell lines
PS3-42.
Influence of Structural Variants of the TRIC-CCT complex´s genes on patient survival and the main molecular pathways related to breast cancer
PS3-43.
In silico identification of ADRA2A-associated miRNA expression as biomarkers for disease-free survival in breast cancer subtypes
PS3-44.
Integrative single-cell transcriptomic analysis unveils alternative polyadenylation modulation in the mouse mammary gland
PS3-45.
Differentiation of 3T3-L1 preadipocytes into beige adipocytes regulate mammary tumor cells behavior
PS3-46.
Soluble factors from the tumor-adipocyte interplay stimulate morphological and metabolic changes in 3T3-L1 adipocytes
PS3-47.
The Kinin B1 Receptor induces the expression and secretion of IL-10 and M-CSF from breast cancer cells, favoring the differentiation and migration of macrophages
PS3-48.
Low-grade inflammation is related to KLK3 levels in breast cancer
PS3-49.
Identification of circulating miRNAs associated to Kaiso and triple negative breast cancer in mice model
PS3-50.
Potential use of PI3K pathway effectors and associated microRNAs as biomarkers of breast cancer prognosis
PS3-51.
Glycerol-3P-Acyltransferase 2 expression in MDA-MB-231 cells modulates the expression of Long Non-Coding RNAs linked to survival prediction in breast cancer patients
PS3-52.
Establishing histopathological criteria for breast cancer research
PS1-04.
Analysis of Akt molecular, subcellular and tumoral code as an explanatory and predictive tool for the effectiveness of therapies against breast cancer